Understanding RNAi
RNA interference (RNAi) is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
![Aln_Icons_RNAi](/sites/default/files/inline-images/Aln_Icons_RNAi.png)
Learn about RNAi and our investigational therapies
Read More ›![Aln_Icons_4Stars](/sites/default/files/inline-images/Aln_Icons_4Stars.png)
Alnylam is focused on 4 Strategic Therapeutic Areas (STArs): genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases
![Caregivers](/sites/default/files/inline-images/Caregivers.png)
Alnylam is dedicated to providing support for affected individuals, families, and caregivers
![Aln_Icons_Interested2](/sites/default/files/inline-images/Aln_Icons_Interested2.png)
Interested in our clinical trials?